Total Payments
$393,116
2024 Payments
$2,104
Companies
34
Transactions
874
Medicare Patients
6,984
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$295,064 (75.1%)
Travel$64,373 (16.4%)
Food & Beverage$17,966 (4.6%)
Consulting$15,489 (3.9%)
Education$223.69 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $242,664 | 103 | 61.7% |
| Travel and Lodging | $64,373 | 74 | 16.4% |
| Honoraria | $52,400 | 12 | 13.3% |
| Food and Beverage | $17,966 | 674 | 4.6% |
| Consulting Fee | $15,489 | 5 | 3.9% |
| Education | $223.69 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $215,529 | 178 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $69,440 | 58 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $60,403 | 54 | $0 (2024) |
| Amgen Inc. | $33,959 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $4,071 | 32 | $0 (2022) |
| ABBVIE INC. | $2,169 | 96 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,078 | 63 | $0 (2024) |
| MAYNE PHARMA INC. | $1,016 | 94 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $777.04 | 25 | $0 (2024) |
| Incyte Corporation | $674.43 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,104 | 90 | ABBVIE INC. ($434.74) |
| 2023 | $2,469 | 112 | AbbVie Inc. ($477.10) |
| 2022 | $7,701 | 93 | Janssen Scientific Affairs, LLC ($3,125) |
| 2021 | $56,862 | 108 | SUN PHARMACEUTICAL INDUSTRIES INC. ($27,874) |
| 2020 | $64,306 | 105 | Janssen Scientific Affairs, LLC ($25,270) |
| 2019 | $86,594 | 133 | Celgene Corporation ($47,373) |
| 2018 | $95,497 | 121 | Celgene Corporation ($94,724) |
| 2017 | $77,584 | 112 | Celgene Corporation ($73,432) |
All Payment Transactions
874 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.88 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.35 | General |
| Category: Immunology | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $50.18 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.58 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.85 | General |
| 09/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.89 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.74 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.74 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,126 | 5,518 | $940,785 | $377,209 |
| 2022 | 25 | 2,136 | 6,284 | $1.2M | $485,300 |
| 2021 | 15 | 1,527 | 3,038 | $448,786 | $112,051 |
| 2020 | 15 | 1,195 | 2,457 | $406,867 | $73,451 |
Total Patients
6,984
Total Services
17,297
Medicare Billing
$1.0M
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 38 | 620 | $290,401 | $124,911 | 43.0% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 46 | 639 | $200,130 | $85,432 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 421 | 601 | $94,833 | $33,835 | 35.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 233 | 291 | $57,810 | $22,320 | 38.6% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 38 | 597 | $42,409 | $17,996 | 42.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 36 | 116 | $39,005 | $16,877 | 43.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 304 | 380 | $44,617 | $12,575 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 178 | 178 | $34,792 | $11,711 | 33.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 158 | 182 | $32,314 | $11,142 | 34.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 250 | 1,307 | $15,289 | $6,230 | 40.7% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 29 | 83 | $12,331 | $5,371 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 57 | $12,732 | $4,767 | 37.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 93 | 110 | $10,844 | $4,075 | 37.6% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 34 | 61 | $7,027 | $2,997 | 42.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $7,454 | $2,938 | 39.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 22 | $6,505 | $2,825 | 43.4% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 15 | 23 | $4,876 | $2,095 | 43.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 40 | 40 | $5,047 | $1,772 | 35.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 40 | $3,992 | $1,366 | 34.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 27 | 35 | $3,083 | $1,328 | 43.1% |
| 77261 | Simple radiation therapy planning | Office | 2023 | 24 | 25 | $3,112 | $1,325 | 42.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $5,142 | $1,106 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,491 | $1,039 | 29.8% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $2,201 | $590.04 | 26.8% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 13 | 19 | $1,270 | $555.18 | 43.7% |
About Dr. Michael Caglia, M.D
Dr. Michael Caglia, M.D is a Internal Medicine healthcare provider based in Midland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1568789550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Caglia, M.D has received a total of $393,116 in payments from pharmaceutical and medical device companies, with $2,104 received in 2024. These payments were reported across 874 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($242,664).
As a Medicare-enrolled provider, Caglia has provided services to 6,984 Medicare beneficiaries, totaling 17,297 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Midland, TX
- Active Since 04/29/2010
- Last Updated 09/08/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568789550
Products in Payments
- Otezla (Drug) $249,129
- TREMFYA (Drug) $38,240
- ILUMYA (Biological) $32,442
- Tremfya (Drug) $31,475
- Ilumya (Biological) $27,843
- SKYRIZI (Biological) $879.51
- DORYX (Drug) $713.23
- OPZELURA (Drug) $584.44
- BOTOX (Biological) $555.25
- COSENTYX (Biological) $492.32
- DUPIXENT (Biological) $489.40
- COSENTYX (Drug) $487.46
- HUMIRA (Biological) $464.08
- VTAMA (Drug) $355.85
- TALTZ (Drug) $354.94
- EUCRISA (Drug) $294.08
- Sotyktu (Drug) $208.22
- ADBRY (Biological) $194.74
- Bimzelx (Biological) $194.47
- Enbrel (Biological) $155.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Midland
Leela Lella, M.d, M.D
Internal Medicine — Payments: $53,199
Internal Medicine $53,199
Dr. Allen Gibson, M.d, M.D
Internal Medicine — Payments: $44,762
Internal Medicine $44,762
Phillip Chae, M.d, M.D
Internal Medicine — Payments: $44,655
Internal Medicine $44,655
John Blamoun, Md, MD
Internal Medicine — Payments: $39,504
Internal Medicine $39,504
Ahmad Subhi, M.d, M.D
Internal Medicine — Payments: $17,187
Internal Medicine $17,187
Andrzej Boguszewski, M.d, M.D
Internal Medicine — Payments: $15,924
Internal Medicine $15,924